Physician profile
Daphne Robert
NPI 1306138086
$5,007.15
in general payments reported to CMS, 2019-2025
10 companies · $1,669 in 2025
The $1,669 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,338 · 2025: $1,669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,237 · Travel and Lodging: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,237.24 |
| Travel and Lodging | $1,769.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,714.30 | 2024 | |
| Paratek Pharmaceuticals, INC. | $923.65 | 2024-2025 | Nuzyra |
| Amgen INC. | $447.42 | 2024-2025 | Krystexxa |
| Kerecis Limited | $250.12 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Stryker Corporation | $164.01 | 2025 | Limflow System |
| Averitas Pharma INC. | $151.42 | 2025 | Qutenza |
| Ani Pharmaceuticals, INC. | $132.77 | 2025 | Purified Cortrophin Gel |
| Organogenesis INC. | $102.47 | 2025 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $71.87 | 2024-2025 | Regranex, Collagenase Santyl |
| Orthofix Medical, INC. | $49.12 | 2024-2025 | Physio-Stim, Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Robert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.